Adverse Drug Reaction Classification System

         

ADR Ontology
ADR Term Hidradenitis
ADR ID BADD_A02068
ADR Hierarchy
23      Skin and subcutaneous tissue disorders
23.02      Skin appendage conditions
23.02.03      Apocrine and eccrine gland disorders
23.02.03.013      Hidradenitis
Description The inflammation of a sweat gland (usually of the apocrine type). The condition can be idiopathic or occur as a result of or in association with another underlying condition. Neutrophilic eccrine hidradenitis is a relatively rare variant that has been reported in patients undergoing chemotherapy, usually for non-Hodgkin lymphomas or leukemic conditions. [MeSH]
MedDRA Code 10020040
MeSH ID D016575; D017497
ADR Severity Grade (FAERS)
ADR Severity Grade (CTCAE) Not Available
Synonym
Hidradenitis | Hidradenitis suppurativa | Sweat gland inflammation | Neutrophilic eccrine hidradenitis | Acne inversa | Verneuil's disease | Hidradenitides | Hydradenitis | Hydradenitides | Hidrosadenitis | Hidrosadenitides | Neutrophilic Eccrine Hidradenitis | Eccrine Hidradenitides, Neutrophilic | Eccrine Hidradenitis, Neutrophilic | Hidradenitides, Neutrophilic Eccrine | Hidradenitis, Neutrophilic Eccrine | Neutrophilic Eccrine Hidradenitides
Drugs Leading to the ADR
Drug IDDrug NameADR Frequency (FAERS)ADR Severity Grade (FAERS)
BADD_D00156Apremilast0.001471%
BADD_D00194Azacitidine0.000112%
BADD_D00195Azathioprine0.000783%
BADD_D00483Clindamycin--
BADD_D00560Cytarabine0.001063%
BADD_D00566Dabrafenib0.000224%
BADD_D00580Dapsone--
BADD_D00676Dimenhydrinate--
BADD_D00725Doxycycline--
BADD_D00852Etonogestrel0.000917%
BADD_D00898Finasteride0.000045%
BADD_D01197Iron--
BADD_D01213Isotretinoin0.002985%
BADD_D01252Leflunomide0.000428%
BADD_D01281Levonorgestrel0.002080%
BADD_D01366Medroxyprogesterone acetate--
BADD_D01397Mesalamine0.000183%
BADD_D01418Methotrexate0.000307%
BADD_D01470Minocycline--
BADD_D01564Nicotine0.000940%
BADD_D01831Prednisolone0.000052%
BADD_D01834Prednisone0.000038%
BADD_D01835Pregabalin0.000052%
BADD_D01933Ribavirin0.008703%
BADD_D01954Rivaroxaban--
BADD_D02066Spironolactone0.000124%
BADD_D02105Tacrolimus0.000446%
BADD_D02165Teriflunomide0.001181%
BADD_D02236Tofacitinib0.002411%
BADD_D02344Vemurafenib0.000302%
The 1th Page    1    Total 1 Pages